PharmaCielo Ltd. (TSXV:PCLO) (OTCPK:PHCEF) has today announced the successful completion of its first commercial export of CBD isolate to Europe. PCLO stock is up 1.58% as a result.
Inaugural ShipmentPharmaCielo is the Canadian parent company of one of Colombia’s leading cultivators and producers of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings. Last month, the company was granted the first CBD isolate export permit by the Colombian government and has wasted no time in moving in on the highly lucrative European market. Today’s shipment was made to the Swiss office of Creso Pharma, an Australian pharmaceutical company ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.